1. 180 IMMUNOPHENOTYPIC ANALYSIS OF ERYTHROID DYSPLASIA IN MYELODYSPLASTIC SYNDROMES. A REPORT ON BEHALF OF THE INTERNATIONAL AND EUROPEAN LEUKEMIANET IMDS-FLOW WORKING GROUP. Issue 1 (April 2015) Authors: Westers, T.M.; Cremers, E.M.P.; Oelschlaegel, U.; Johansson, U.; Bettelheim, P.; Witte, B.I.; Porta, M.G. Della; Kern, W.; van de Loosdrecht, A.A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 219 RELATION BETWEEN MOLECULAR MUTATIONS AND ABERRANTLY EXPRESSED ANTIGENS IN MYELODYSPLASTIC SYNDROMES. Issue 1 (April 2015) Authors: Kern, W.; Ogawa, S.; Haferlach, C.; Schnittger, S.; Haferlach, T. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BCL-2 Inhibition by ABT-199 Potently Induces Cell Death in MDS Progenitors Despite High-Risk Mutations in ASXL1, RUNX1, TP53 or EZH2. (April 2017) Authors: Jilg, S.; Reidel, V.; Kauschinger, J.; Müller-Thomas, C.; Hauch, R.; Schauwecker, J.; Burkhard, S.; Höckendorf, U.; Peschel, C.; Kern, W.; Haferlach, T.; Slotta-Huspenina, J.; Götze, K.S.; Jost, P.J. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical. (March 2015) Authors: Orasch, C.; Averbuch, D.; Mikulska, M.; Cordonnier, C.; Livermore, D.M.; Gyssens, I.C.; Klyasova, G.; Engelhard, D.; Kern, W.; Viscoli, C.; Akova, M.; Marchetti, O. Journal: Clinical microbiology and infection Issue: Volume 21:Number 3(2015:Mar.) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. German experience with screening and healthcare in refugee and asylum seeker reception camps. (December 2016) Authors: Kern, W. Journal: International journal of infectious diseases Issue: Volume 53(2016:Dec.)Supplement Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ICSH: on board for new projects. (June 2014) Authors: Zini, G.; Kern, W.; Brereton, M.; Stephens, A. D. Journal: International journal of laboratory hematology Issue: Volume 36:Number 3(2014:Jun.) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Initial flow cytometric evaluation of the Clearllab lymphoid screen. Issue 5 (8th December 2017) Authors: Hedley, B.D.; Cheng, G.; Luider, J.; Kern, W.; Lozanski, G.; Chin‐Yee, I.; Lowes, L.E.; Keeney, M.; Careaga, D.; Magari, R.; Tejidor, L. Journal: Cytometry Issue: Volume 94:Issue 5(2018) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P411: SF3B1 MUTATIONS IN AML ARE STRONGLY ASSOCIATED WITH MECOM REARRANGEMENTS AND MAY BE INDICATIVE OF AN MDS PRE-PHASE. (23rd June 2022) Authors: Huber, S.; Hutter, S.; Meggendorfer, M.; Hoermann, G.; Walter, W.; Baer, C.; Kern, W.; Haferlach, T.; Haferlach, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P735: THE ROLE OF SF3B1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Huber, S.; Hutter, S.; Meggendorfer, M.; Hoermann, G.; Walter, W.; Baer, C.; Kern, W.; Haferlach, T.; Haferlach, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P744: UNBALANCED TRANSLOCATION DER(1;7)(Q10;P10) AS A DISTINCT SUBTYPE IN MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Okuda, R.; Ochi, Y.; Chonabayashi, K.; Hiramoto, N.; Sanada, M.; Handa, H.; Kasahara, S.; Sato, S.; Kanemura, N.; Kitano, T.; Watanabe, M.; Kern, W.; Creignou, M.; Shiraishi, Y.; Watanabe, M.; Usuki, K.; Imashuku, S.; Hellstrom-Lindberg, E.; Haferlach, T.; Chiba, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗